Acthar and Tinnitus - a phase IV clinical study of FDA data

Summary:

Tinnitus is reported as a side effect among people who take Acthar (corticotropin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Gilenya, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Tinnitus when taking Acthar. It is created by eHealthMe based on reports of 4,932 people who have side effects when taking Acthar from the FDA, and is updated regularly.

What is Acthar?

Acthar has active ingredients of corticotropin. eHealthMe is studying from 4,948 Acthar users. Check the latest studies of Acthar.

What is Tinnitus?

Tinnitus (a ringing in the ears) is found to be associated with 1,669 drugs and 3,059 conditions by eHealthMe. Check the latest studies of Tinnitus.

On Jul, 15, 2026

4,932 people reported to have side effects when taking Acthar.
Among them, 16 people (0.32%) have Tinnitus.

Among these 16 people:

How long have people been on Acthar when they have Tinnitus? *

What is the gender of people who have Tinnitus when taking Acthar? *

female: 68.75 %
male: 31.25 %

What is the age of people who have Tinnitus when taking Acthar? *

What are other drugs people take besides Acthar? *

What are other side effects people have besides Tinnitus? *

Dizziness: 6 people, 37.50%
Memory Loss: 6 people, 37.50%
Hemiparesis (weakness on one side of the body): 5 people, 31.25%
Urticaria (rash of round, red welts on the skin that itch intensely): 5 people, 31.25%
Irritability: 5 people, 31.25%
Hemiplegia (paralysis of one side of the body): 5 people, 31.25%
Lip Swelling: 5 people, 31.25%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 5 people, 31.25%
Confusional State: 5 people, 31.25%
Drowsiness: 5 people, 31.25%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 31.25%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 18.75%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 2 people, 12.50%
Thyroid Diseases: 1 person, 6.25%
Sinusitis (inflammation of sinus): 1 person, 6.25%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 1 person, 6.25%
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 1 person, 6.25%
Pain In Extremity: 1 person, 6.25%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.25%
Migraine (headache): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Acthar and have Tinnitus?

- Check whether Tinnitus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acthar:

Acthar (4,948 reports)

Tinnitus treatments and more:

Tinnitus (58,552 reports)

Browse all side effects of Acthar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tinnitus:

Tinnitus (1,669 drugs)

Browse all the conditions that are associated with Tinnitus:

Tinnitus (3,059 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on corticotropin (the active ingredients of Acthar) and Acthar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.